Funds will be raised by way of issue of upto 108,00,000 equity shares of Re 1 each on preferential basis for cash to Aranda, a foreign portfolio investor
Glenmark Pharmaceuticals informed the stock exchanges that Temasek Holdings, the investment arm of the Singapore government, is considering investing in the company through its wholly-owned subsidiary Aranda Investments (Mauritius), (Aranda) in equity shared to be issued by the company on a preferential basis. At the recently held board meeting in Mumbai, Glenmark decided to raise funds by way of issue of upto 108,00,000 equity shares of Re 1 each on preferential basis for cash to Aranda, a foreign portfolio investor at a price of Rs 875 per equity share aggregating to Rs 945 crores, subject to the requisite approvals of the shareholders and any regulatory authorities, as may be required.
Comments are closed.